 or Ledipasvir/Sofosbuvir (Harvoni) plus weight-based Ribavirin) - 00 wk   DAA-experienced including NS0A inhibitors with or without compensated cirrhosis   Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) - 00 wk                                                                                                                                                                                               Genotype 0 